Who is sponsoring NCT03055702?

NCT03055702 is sponsored by The University of Hong Kong.

What drugs are being tested in NCT03055702?

Interventions in NCT03055702: Mobile phone text message reminder.

What condition does NCT03055702 study?

NCT03055702 studies Appointments and Schedules, Diabetes Mellitus, Type 2.

Is NCT03055702 still recruiting?

NCT03055702 is currently status unknown. Last updated 16 February 2017.

Last reviewed 2017-02-16 · How we verify

NCT03055702

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM Patients

Status unknown NA Last updated 16 February 2017

What this trial tests

NA trial testing Mobile phone text message reminder in Appointments and Schedules in 270 participants. Status unknown.

Timeline

1 November 2016

Primary endpoint
30 June 2017

30 March 2018

Quick facts

Lead sponsor	The University of Hong Kong
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	270
Start date	1 November 2016
Primary completion	30 June 2017
Estimated completion	30 March 2018
Sites	1 location across Hong Kong

Drugs / interventions tested

Mobile phone text message reminder

Conditions studied

Appointments and Schedules — all drugs for Appointments and Schedules →
Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

The University of Hong Kong

Who can join

18 and older, any sex, with Appointments and Schedules or Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized controlled trial of patients with type 2 diabetes mellitus with multiple appointments into short message service group and control group. The attendance rate of these two groups of patients will be compared.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03055702 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 16 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03055702.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing